CARESENG CANCER THERAPY

Careseng is a product produced from ginseng that contains greater than 99% anti-cancer ginsengosides.  The two main compounds are Rh2 and aglycon sapogenins that have shown in initial clinical trials to have strong cancer-inhibitory effects.  Laboratory data and preliminary clinical observation strongly indicate that in combination with conventional chemotherapy, the ginsengosides dramatically sensitize cancer cells to conventional treatments.  The compounds found within Careseng are useful for multi-drug resistant cancer cells, which are common in late stage cancer patients.  Scientific data strongly support that Careseng is a non-toxic natural supplement for Cancer patients, especially for those with late stage and drug resistant cancer of various types.

MORE ABOUT CARESENG:

• Produced by Pegasus Pharmaceuticals by patented technology.
• Contains >99% anti-cancer ginsengosides, an amount equivalent to greater than 100 lbs of ginseng.
• Has been used in clinics for over 2 ½ years, with no adverse effects on more than 500 patients in Dr. Jim Chan's clinic.
• Laboratory studies on cultured cancer-cells resulted in rapid cancer-cell death.
• Clinical observation I with 40 patients with various types of cancer including lung, colon, liver, and breast after 60 days resulted in 75% tumor inhibition and no toxicity.
• Clinical Observation II in 15 patients with breast, colon, brain, liver and ovarian cancer showed 80% inhibition with no adverse side-effects.

For more information contact IHC-Online 403-288-4880 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it